论文部分内容阅读
玻璃体术后的合并症之一是眼内大量纤维蛋白渗出和血凝块形成。这些合并症多半在术后早期出现,因此刚手术后观察眼底困难,进一步发生再增殖的情况也不少见。近年来以溶解玻璃体术后发生的纤维蛋内膜为目的,限内注入组织纤维蛋白溶酶原激活酶(t—PA)已被广泛认识。但t—PA在日本只是最近才有出售,且价格昂贵,难以普及。作者为溶解纤维蛋白和血凝块,采用眼内注入尿激酶(UK),取得了良好的疗效。对象及方法从1990年4月到1991年5月,作者以15例15眼玻璃体术后眼为对象,其中增殖性糖尿病视网膜病变3眼,增殖性玻璃体视网膜病变10眼,二
One of the complications after vitreous surgery is massive intraocular fibrin exudation and clot formation. Most of these complications appear in the early postoperative period, so after fundus observation, it is not uncommon to see further proliferation. In recent years to dissolve vitreous humor fibrin endometrium for the purpose of limited tissue injection of tissue plasminogen activator (t-PA) has been widely recognized. However, t-PA has only recently been sold in Japan and is expensive and difficult to popularize. The author of the dissolution of fibrin and blood clots, the use of intraocular injection of urokinase (UK), and achieved good results. Subjects and methods From April 1990 to May 1991, the author of 15 cases of 15 cases of vitreous ophthalmology as the object, including 3 cases of proliferative diabetic retinopathy, proliferative vitreoretinopathy 10 eyes, two